Value £110,600,000

Basecamp Research

VC Funding

Series C £100m+ Cross-border

Healthcare & Biotech Published 25 September 2026

Summary

London-based biotech startup Basecamp Research has secured $140 million (£106m) in an oversubscribed Series C funding round to advance its AI-designed therapeutics platform.

Summary of transaction details:

Value: $140 million (£106m)
Sector: Healthcare & Biotech
Advisor: Not disclosed
Key Entities: Basecamp Research, S32, Menlo Ventures, Catalio Capital Management, NVIDIA, Roche (André Hoffmann)
Location: London, United Kingdom

Note: The capital injection will accelerate Basecamp Research's development of EDEN, its biological foundation model used to design programmable in vivo cell therapies targeting cancer and autoimmune diseases.

Lead Investor / Acquirer

S32

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Series C prioritised

VC Funding

Scan.com

£67,220,000

Sept 2026

VC Funding

Stream

£67,000,000

Jan 2024

VC Funding

Babylon Health

£24,490,661

May 2020

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

View Company Details

Financials, officers, full deal history

Original Source

View the original press release or news article describing this transaction in full.

Read Original Post

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.